Another key focus of the present study, phosphatase and tensin homolog (PTEN), has emerged as a well-established tumor suppressor gene, such that its inactivation or mutation is implicated in a plethora of malignancies, such as breast, thyroid, colon, and endometrial cancers [14,15]. This evidence concerns the gene PTEN and neoplasm.